Literature DB >> 1954341

Redirecting Pseudomonas exotoxin.

D FitzGerald1, I Pastan.   

Abstract

Pseudomonas exotoxin (PE) is a three-domain bacterial toxin that kills mammalian cells by gaining entry to the cytosol and inactivating protein synthesis. The pathway of toxin entry includes binding to a surface receptor, internalization via coated pits and endosomes, proteolytic processing, reduction of disulfide bonds and finally the translocation of an enzymatically active C-terminal fragment to the cytosol. Once in the cytosol this fragment inhibits protein synthesis by ADP ribosylating elongation factor 2. Because of its potency PE and its derivatives have been directed to kill various target cells. It is hoped this strategy will lead to the development of a novel kind of therapeutic agent for the treatment of various human diseases including cancer, AIDS and various immunological disorders.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954341

Source DB:  PubMed          Journal:  Semin Cell Biol        ISSN: 1043-4682


  7 in total

Review 1.  Targeted kill: from umbrellas to monoclonal antibodies.

Authors:  V S Byers; R W Baldwin
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

2.  Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies.

Authors:  M Varughese; A Chi; A V Teixeira; P J Nicholls; J M Keith; S H Leppla
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

3.  Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.

Authors:  Assaf Shapira; Meital Gal-Tanamy; Limor Nahary; Dana Litvak-Greenfeld; Romy Zemel; Ran Tur-Kaspa; Itai Benhar
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

4.  Selective eradication of cancer cells by delivery of adenovirus-based toxins.

Authors:  Shiran Shapira; Assaf Shapira; Diana Kazanov; Gil Hevroni; Sarah Kraus; Nadir Arber
Journal:  Oncotarget       Date:  2017-06-13

Review 5.  Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology.

Authors:  Olga Shilova; Elena Shramova; Galina Proshkina; Sergey Deyev
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

6.  Tat-mediated delivery of heterologous proteins into cells.

Authors:  S Fawell; J Seery; Y Daikh; C Moore; L L Chen; B Pepinsky; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 12.779

Review 7.  Immunotoxins: the role of the toxin.

Authors:  Antonella Antignani; David Fitzgerald
Journal:  Toxins (Basel)       Date:  2013-08-21       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.